KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Exact Sciences (EXAS) over the last 9 years, with Sep 2025 value amounting to $189.3 million.

  • Exact Sciences' Shares Outstanding (Diluted Average) rose 2.42% to $189.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.3 million, marking a year-over-year increase of 2.42%. This contributed to the annual value of $185.3 million for FY2024, which is 2.32% up from last year.
  • Exact Sciences' Shares Outstanding (Diluted Average) amounted to $189.3 million in Q3 2025, which was up 0.19% from $188.9 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Shares Outstanding (Diluted Average) ranged from a high of $189.3 million in Q3 2025 and a low of $169.4 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $184.2 million, with a median of $184.3 million in 2024.
  • Data for Exact Sciences' Shares Outstanding (Diluted Average) shows a peak YoY climbed of 14.54% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Exact Sciences' Shares Outstanding (Diluted Average) stood at $171.3 million in 2021, then climbed by 2.92% to $176.4 million in 2022, then increased by 2.70% to $181.1 million in 2023, then increased by 2.32% to $185.3 million in 2024, then increased by 2.42% to $189.3 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $189.3 million for Q3 2025, versus $188.9 million for Q2 2025 and $186.8 million for Q1 2025.